Rate My Professor Jack Dummer

Dummer has an extensive publication record in respiratory medicine and related fields. His highly cited works include "Analysis of biogenic volatile organic compounds in human health and disease" (2011, 148 citations), "Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide" (2009, 111 citations), "Measurement of breath acetone concentrations by selected ion flow tube mass spectrometry in type 2 diabetes" (2011, 97 citations), "Protection by dexamethasone of the functional desensitization to β2-adrenoceptor-mediated responses in human lung mast cells" (1997, 53 citations), and "Accurate, reproducible measurement of acetone concentration in breath using selected ion flow tube-mass spectrometry" (2010, 49 citations). Recent publications feature "Inhaled Antibiotic and Biologic Formulations Targeting Pseudomonas aeruginosa" (2026), "Lung function and cardiovascular risk at age 45 in a cohort of the general population" (2024), "Evaluation of risk prediction scores for adults hospitalised with COVID-19" (2024), and studies on long-acting bronchodilator use and acute coronary syndrome risk (2021). Additionally, his research explores inhaled rifampicin formulations for high-dose delivery in tuberculosis treatment, including polymorphic forms and clinical preparation considerations (2018-2023). Dummer also investigates biomarkers like hydrogen cyanide in Pseudomonas infections and chloramines in breath. Clinically, he provides respiratory services at Dunedin Hospital. His work bridges clinical practice, epidemiology, and innovative diagnostics in respiratory health.